Board of Directors
Peter Høngaard Andersen
Chairman of the Board, Scandion Oncology.
Holds a degree in Chemistry, Biochemistry and medicine.
Extensive drug discovery and development experience from Novo Nordisk and Lundbeck latest as EVP and Head of Research and corporate patents.
Founder of Innovation Fund Denmark and Managing Director until May 2019 and chairing Innovative Medicines Initiative (IMI) from 2009 – 2014.
Co-founder of e.g. Acadia Pharmaceuticals, Zealand Pharma, Glycom, Epitherapeutics, Prexton Therapeutics.
Vice-Chairman of the Board, Scandion Oncology.
Chairman of the Board, Lyngsoe Systems, Dubex and Symbion.
Boardmember in EG, Accelerace, Prodata Consult, BLOXHUB (vice chair), et al.
Steering Committee Chairman in Copenhagen Healthtech Cluster and Innofounder.
Professor Lund University.
Co-founder of Immnovia AB, Senzagen AB, BioInvent International AB, Alligator BioScience AB.
Christian Vinding Thomsen
Partner, Bech-Bruun Law Firm.
Life Science specialist (M&A and regulatory).
Professional board member.
vVD, CFO and co-founder of Saniona (M.Sc., MBA).
CEO of Fertilizer Invest ApS.
Previously, CFO and co-founder of Symphogen A/S.